Collegium Pharmaceutical, Inc. COLL Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $62.87M-9.1% | $69.19M+43.7% | $48.16M+289% | -$25.46M-136% | ||
| $4.18M+8.5% | $3.86M+10.3% | $3.5M+30.3% | $2.68M+54.6% | ||
| $41.91M+29.3% | $32.4M+19.4% | $27.14M+18.6% | $22.87M-5.7% | ||
| $329.32M+53.9% | $213.98M-22.1% | $274.75M+121% | $124.23M+20.0% | ||
| $1.74M+5.3% | $1.65M+258% | $461K-71.6% | $1.62M-16.6% | ||
| -$63.53M+77.9% | -$287.76M-306% | -$70.81M+87.7% | -$573.69M-29,411% | ||
| $635.56M+490% | $107.81M-33.7% | $162.5M— | —— | ||
| -$110.25M— | —— | -$140.18M— | —— | ||
| $155.55M— | —— | —— | —— | ||
| $327.58M+54.1% | $212.57M-22.5% | $274.29M+124% | $122.61M+20.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Collegium Pharmaceutical, Inc. generate?
- Collegium Pharmaceutical, Inc. (COLL) generated $331.0M in operating cash flow over the trailing twelve months.
- What is Collegium Pharmaceutical, Inc.'s free cash flow?
- After $1.2M of capital expenditures, Collegium Pharmaceutical, Inc.'s free cash flow was $329.8M over the trailing twelve months, up 60.3% year over year.
- Where does Collegium Pharmaceutical, Inc.'s cash flow data come from?
- Every line is extracted from Collegium Pharmaceutical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
